Skip to main content
Table of Contents
Print

What are the penalties for unauthorised cannabis use in treating fibromyalgia? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Despite the growing conversation around medical cannabis, unauthorised cannabis use for fibromyalgia  remains illegal in the UK unless prescribed by a licensed specialist. Even if used solely for symptom relief, patients without a legal prescription can face serious consequences. The law draws a clear line between regulated medical use and recreational or unapproved access. 

The risks tied to unauthorised cannabis use include more than just fines they can extend to long-term legal consequences and scrutiny from drug enforcement authorities. 

Legal outcomes for unauthorised cannabis use in the UK 

Here are the key legal risks associated with unapproved cannabis use for fibromyalgia patients: 

Criminal Charges for Possession 

Being caught with cannabis without a valid prescription can lead to a police warning, a fine of up to £90, or prosecution in serious cases. 

Supply and Intent to Distribute 

Sharing cannabis with another patient may be viewed as supply, carrying harsher penalties including imprisonment of up to 14 years. 

Drug Enforcement Surveillance 

Repeat offences can result in increased monitoring, legal escalation, and inclusion in local drug enforcement records. 

Impact on Employment and Travel 

A drug conviction can damage your professional record and restrict travel to countries with strict drug policies. 

Disqualification from Legal Access 

Patients who engage in unauthorised cannabis use may find it harder to receive cannabis legally from medical clinics later on. 

The safest way to explore cannabis as a fibromyalgia treatment is through legal medical channels. Avoiding legal consequences means working with registered doctors and adhering to current UK law. 

If you’re exploring cannabis treatment options for fibromyalgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Fibromyalgia. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories